These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 10802611)

  • 1. Problem solving for tumor immunotherapy.
    Gouttefangeas C; Rammensee HG
    Nat Biotechnol; 2000 May; 18(5):491-2. PubMed ID: 10802611
    [No Abstract]   [Full Text] [Related]  

  • 2. Functional regulation of immunoproteasomes and transporter associated with antigen processing.
    Hwang LY; Lieu PT; Peterson PA; Yang Y
    Immunol Res; 2001; 24(3):245-72. PubMed ID: 11817324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene transfer of human interferon gamma complementary DNA into a renal cell carcinoma line enhances MHC-restricted cytotoxic T lymphocyte recognition but suppresses non-MHC-restricted effector cell activity.
    Schendel DJ; Falk CS; Nössner E; Maget B; Kressenstein S; Urlinger S; Tampé R; Gansbacher B
    Gene Ther; 2000 Jun; 7(11):950-9. PubMed ID: 10849555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective immunotherapy of cancer in MUC1-transgenic mice using clonal cytotoxic T lymphocytes directed against an immunodominant MUC1 epitope.
    Heukamp LC; van Hall T; Ossendorp F; Burchell JM; Melief CJ; Taylor-Papadimitriou J; Offringa R
    J Immunother; 2002; 25(1):46-56. PubMed ID: 11926165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma?
    Atkins D; Ferrone S; Schmahl GE; Störkel S; Seliger B
    J Urol; 2004 Feb; 171(2 Pt 1):885-9. PubMed ID: 14713847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunology: professional secrets.
    Roy CR
    Nature; 2003 Sep; 425(6956):351-2. PubMed ID: 14508466
    [No Abstract]   [Full Text] [Related]  

  • 8. Two mechanisms for tumor evasion of preexisting cytotoxic T-cell responses: lessons from recurrent tumors.
    Zheng P; Sarma S; Guo Y; Liu Y
    Cancer Res; 1999 Jul; 59(14):3461-7. PubMed ID: 10416611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of the proteasome inhibitor lactacystin on the presentation of transporter associated with antigen processing (TAP)-dependent and TAP-independent peptide epitopes by class I molecules.
    Bai A; Forman J
    J Immunol; 1997 Sep; 159(5):2139-46. PubMed ID: 9278300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mutation in the ATP-binding region of JAK1, identified in human uterine leiomyosarcomas, results in defective interferon-gamma inducibility of TAP1 and LMP2.
    Hayashi T; Kobayashi Y; Kohsaka S; Sano K
    Oncogene; 2006 Jul; 25(29):4016-26. PubMed ID: 16474838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-gamma exposes a cryptic cytotoxic T lymphocyte epitope in HIV-1 reverse transcriptase.
    Sewell AK; Price DA; Teisserenc H; Booth BL; Gileadi U; Flavin FM; Trowsdale J; Phillips RE; Cerundolo V
    J Immunol; 1999 Jun; 162(12):7075-9. PubMed ID: 10358150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of human lymphocyte antigen class I antigen-processing machinery defects in renal cell carcinoma lesions with special emphasis on transporter-associated with antigen-processing down-regulation.
    Seliger B; Atkins D; Bock M; Ritz U; Ferrone S; Huber C; Störkel S
    Clin Cancer Res; 2003 May; 9(5):1721-7. PubMed ID: 12738726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transporter (TAP)- and proteasome-independent presentation of a melanoma-associated tyrosinase epitope.
    Wölfel C; Drexler I; Van Pel A; Thres T; Leister N; Herr W; Sutter G; Huber C; Wölfel T
    Int J Cancer; 2000 Nov; 88(3):432-8. PubMed ID: 11054673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteasomes can either generate or destroy MHC class I epitopes: evidence for nonproteasomal epitope generation in the cytosol.
    Luckey CJ; King GM; Marto JA; Venketeswaran S; Maier BF; Crotzer VL; Colella TA; Shabanowitz J; Hunt DF; Engelhard VH
    J Immunol; 1998 Jul; 161(1):112-21. PubMed ID: 9647214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer.
    Romero JM; Jiménez P; Cabrera T; Cózar JM; Pedrinaci S; Tallada M; Garrido F; Ruiz-Cabello F
    Int J Cancer; 2005 Feb; 113(4):605-10. PubMed ID: 15455355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genes encoded in the major histocompatibility complex affecting the generation of peptides for TAP transport.
    Cerundolo V; Kelly A; Elliott T; Trowsdale J; Townsend A
    Eur J Immunol; 1995 Feb; 25(2):554-62. PubMed ID: 7875220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapeutic agents in low noncytotoxic concentrations increase immunogenicity of human colon cancer cells.
    Kaneno R; Shurin GV; Kaneno FM; Naiditch H; Luo J; Shurin MR
    Cell Oncol (Dordr); 2011 Apr; 34(2):97-106. PubMed ID: 21290210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome.
    Meissner M; Reichert TE; Kunkel M; Gooding W; Whiteside TL; Ferrone S; Seliger B
    Clin Cancer Res; 2005 Apr; 11(7):2552-60. PubMed ID: 15814633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma.
    Atkins D; Breuckmann A; Schmahl GE; Binner P; Ferrone S; Krummenauer F; Störkel S; Seliger B
    Int J Cancer; 2004 Mar; 109(2):265-73. PubMed ID: 14750179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In situ analysis of the antigen-processing machinery in acute myeloid leukaemic blasts by tissue microarray.
    Hoves S; Aigner M; Pfeiffer C; Laumer M; Obermann EC; Mackensen A
    Leukemia; 2009 May; 23(5):877-85. PubMed ID: 19148137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.